United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $387.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $18.6M | 4.8% |
| Other Investing | $190.6M | 49.2% |
| Working Capital | $26.2M | 6.8% |
| Net Cash Flow | $151.8M | 39.2% |